Activation of voltage-gated sodium current and inhibition of erg-mediated potassium current caused by telmisartan, an antagonist of angiotensin II type-1 receptor, in HL-1 atrial cardiomyocytes

被引:21
作者
Chang, Wei-Ting [1 ,2 ]
Wu, Sheng-Nan [3 ]
机构
[1] Chi Mei Med Ctr, Div Cardiovasc Med, Tainan, Taiwan
[2] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan, Taiwan
关键词
action potential; cardiomyocyte; current kinetics; erg-mediated K+ current; Telmisartan; voltage-gated Na+ current; TUMOR GH(3) CELLS; CONVERTING-ENZYME; ION CURRENTS; ANG-II; CHANNEL; RAT; FIBRILLATION; HEART; INACTIVATION; RANOLAZINE;
D O I
10.1111/1440-1681.12943
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Telmisartan (TEL) is a non-peptide blocker of angiotensin II type-1 (AT(1)) receptor. However, the mechanisms through which this drug interacts directly with ion currents in hearts remain largely unclear. Herein, we aim to investigate the effects of TEL the on ionic currents and membrane potential of murine HL-1 cardiomyocytes. In whole-cell recordings, addition of TEL stimulated the peak and late components of voltage-gated Na+ currents (I-Na) with different potencies. The EC50 values required to achieve the stimulatory effect of this drug on peak and late I-Na were 0.2 and 1.2 mu mol/L, respectively, and the current-voltage relationship of peak I-Na shifted toward less-depolarized potentials during exposure to TEL. Telmisartan not only increased peak I-Na but also prolonged the inactivation time course of late I-Na. Amiodarone (Amio) or ranolazine (Ran), but not angiotensin II, could reverse TEL-mediated effects. The drug enhanced the recovery rate of I-Na inactivation and exerted an inhibitory effect on erg-mediated K+ and L-type Ca2+ currents. In whole-cell current-clamp recordings, addition of the drug resulted in prolongation of the duration of action potentials (APs) in a dose-dependent manner in HL-1 cells; Amio or Ran could reverse this increase in AP durations. Telmisartan-mediated prolongation of AP was attenuated in KCNH2 siRNA-transfected HL-1 cells. In cultured smooth muscle cells of the human coronary artery, TEL enhanced I-Na amplitudes and slowed current inactivation. Stimulation by TEL of I-Na in HL-1 cells did not simply increase current magnitude but altered current kinetics, thereby suggesting state-dependent activation. Telmisartan may have greater affinity to the open/inactivated state than to the resting state residing in Na-V channels. Collectively, TEL-mediated stimulation of I-Na and inhibition of I-K(erg) could be an important ionic mechanism underlying the increased cell excitability of HL-1 cells; these actions, however, cannot be entirely explained by its blockade of AT(1) receptor.
引用
收藏
页码:797 / 807
页数:11
相关论文
共 50 条
  • [31] Telmisartan decreases atrial electromechanical delay in patients with newly diagnosed essential hypertension
    Sengul, Cihan
    Cevik, Cihan
    Ozveren, Olcay
    Oduncu, Vecih
    Sunbul, Aysegul
    Kilicarslan, Fethi
    Semiz, Ender
    Dindar, Ismet
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2012, 45 (02) : 123 - 128
  • [32] Differential regulation of tefluthrin and telmisartan on the gating charges of INa activation and inactivation as well as on resurgent and persistent INa in a pituitary cell line (GH3)
    So, Edmund Cheung
    Wu, Sheng-Nan
    Lo, Yi-Ching
    Su, Kevin
    [J]. TOXICOLOGY LETTERS, 2018, 285 : 104 - 112
  • [33] The actions of mdivi-1, an inhibitor of mitochondrial fission, on rapidly activating delayed-rectifier K+ current and membrane potential in HL-1 murine atrial cardiomyocytes
    So, Edmund Cheung
    Hsing, Chung-Hsi
    Liang, Chia-Hua
    Wu, Sheng-Nan
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 683 (1-3) : 1 - 9
  • [34] Stangier J, 2000, J CLIN PHARMACOL, V40, P1312
  • [35] Electropharmacological properties of telmisartan in blocking hKv1.5 and HERG potassium channels expressed on Xenopus laevis oocytes
    Tu, Dan-na
    Liao, Yu-hua
    Zou, An-ruo
    Du, Yi-mei
    Run, Qi
    Wang, Xian-pei
    Li, Lu
    [J]. ACTA PHARMACOLOGICA SINICA, 2008, 29 (08) : 913 - 922
  • [36] Effects of Ivabradine and Ranolazine in Patients With Microvascular Angina Pectoris
    Villano, Angelo
    Di Franco, Antonino
    Nerla, Roberto
    Sestito, Alfonso
    Tarzia, Pierpaolo
    Lamendola, Priscilla
    Di Monaco, Antonio
    Sarullo, Filippo Maria
    Lanza, Gaetano Antonio
    Crea, Filippo
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (01) : 8 - 13
  • [37] Voltage-gated sodium channels in cardiac microvascular endothelial cells
    Walsh, KB
    Wolf, MB
    Fan, JP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (02): : H506 - H512
  • [38] Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice
    Wan, Elaine
    Abrams, Jeffrey
    Weinberg, Richard L.
    Katchman, Alexander N.
    Bayne, Joseph
    Zakharov, Sergey I.
    Yang, Lin
    Morrow, John P.
    Garan, Hasan
    Marx, Steven O.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (01) : 112 - 122
  • [39] RETRACTED: Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation (Retracted Article)
    Wang, Lingxin
    Zellmer, Shannon G.
    Printzenhoff, David M.
    Castle, Neil A.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (20) : 4905 - 4918
  • [40] Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats
    Wang, Wei-wei
    Zhang, Fei-long
    Chen, Jian-hua
    Chen, Xue-hai
    Fu, Fa-yuan
    Tang, Mi-rong
    Chen, Liang-long
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2015, 93 (08) : 657 - 665